A drug that actually slows or reverses the brain damage inflicted by Parkinson’s disease, rather than just alleviates its often debilitating symptoms, remains elusive. But Prevail Therapeutics, a startup just launched in New York, has become the latest to try. This morning, the Silverstein Foundation, a nonprofit organization formed by OrbiMed partner Jonathan Silverstein, announced […]
NYS Entity Status
NYS Filing Date
JULY 22, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC NOT-FOR-PROFIT CORPORATION
2014 - GLOBAL FUTURE EDUCATION FOUNDATION AND INSTITUTE, LTD.
AROUND THE WEB
- For Parkinson’s, Two New Drugs Coming As Prevail Gets Started in NY
By Ben Fidler - Wednesday Aug 9, 2017
- NY State Comptroller Helps Stakeholders Take Action on Climate and Food
By Marian Conway - Thursday Jul 13, 2017
The changing environment, specifically climate change, is becoming a major piece of the global economic puzzle. Decisions are now increasingly based not just on the bottom line, but on the Earth’s future.
- “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
By Ben Fidler - Wednesday Jun 7, 2017
Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]
- Cleveland Clinic Receives $10 Million for Expansion of Eye Institute
By email@example.com (Mitch Nauffts) - Monday Jun 5, 2017
The gift from the Timken Foundation of Canton will support an expansion of the Cole Eye Institute and the creation of the Louise Timken Ophthalmic Education Center....
- New York
Wednesday Nov 4, 2009
On Oct. 14, Bruce Wasserstein -- CEO of Lazard. Ltd. and owner of New York magazine -- died suddenly. The event had the makings of a classic New York article:Financier-Owner Dies! What's Next For New York Magazine? Speculation about the magazine's future did appear. Callous? Perhaps! Downright ghoulish? Maybe. But, hey, this ispublishing and this is New York! You got a problem with that?